sodium-butyrate and norisoboldine

sodium-butyrate has been researched along with norisoboldine* in 1 studies

Other Studies

1 other study(ies) available for sodium-butyrate and norisoboldine

Article	Year
Synthesis of norisoboldine derivatives and bioactivity assay for inducing the generation of regulatory T cells. Bioorganic & medicinal chemistry letters, 2021, 04-01, Volume: 37 In this study, we used chemical modification to improve the pharmacological activity of norisoboldine (NOR). A new NOR-benzoic acid derivative, named DC-01, showed more potent induction of Treg cell differentiation than NOR. The in vitro effective concentration of DC-01 (1 μM) is about an order of magnitude lower than that of NOR (10 μM). DC-01 (28, 56 mg/kg) showed better amelioration of dextran sodium sulfate-induced colitis in mice than NOR (20, 40 mg/kg), and DC-01 (28 mg/kg) increased the number of Treg cells slightly better than NOR (20 mg/kg). In summary, DC-01 exerts more potent induction of Treg cell generation, which might be a candidate drug for the treatment of inflammation- and immune-related diseases. Topics: Alkaloids; Animals; Cell Differentiation; Cell Survival; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, Drug; Mice; Molecular Structure; Structure-Activity Relationship; T-Lymphocytes, Regulatory; Tumor Cells, Cultured	2021

Article

Year

Synthesis of norisoboldine derivatives and bioactivity assay for inducing the generation of regulatory T cells.

Bioorganic & medicinal chemistry letters, 2021, 04-01, Volume: 37

In this study, we used chemical modification to improve the pharmacological activity of norisoboldine (NOR). A new NOR-benzoic acid derivative, named DC-01, showed more potent induction of Treg cell differentiation than NOR. The in vitro effective concentration of DC-01 (1 μM) is about an order of magnitude lower than that of NOR (10 μM). DC-01 (28, 56 mg/kg) showed better amelioration of dextran sodium sulfate-induced colitis in mice than NOR (20, 40 mg/kg), and DC-01 (28 mg/kg) increased the number of Treg cells slightly better than NOR (20 mg/kg). In summary, DC-01 exerts more potent induction of Treg cell generation, which might be a candidate drug for the treatment of inflammation- and immune-related diseases.

Topics: Alkaloids; Animals; Cell Differentiation; Cell Survival; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, Drug; Mice; Molecular Structure; Structure-Activity Relationship; T-Lymphocytes, Regulatory; Tumor Cells, Cultured

2021